The advanced therapeutics pharmaceutical outsourcing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Advanced Therapeutics Pharmaceutical Outsourcing Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The advanced therapeutics pharmaceutical outsourcing market size has grown strongly in recent years. It will grow from $7.64 billion in 2023 to $8.07 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to growth in biopharmaceutical infrastructure, regulatory compliance, increasing demand for novel drugs to treat chronic and life-threatening diseases, improved efficiency, and growing demand for personalized medicine.
The advanced therapeutics pharmaceutical outsourcing market size is expected to see steady growth in the next few years. It will grow to $9.76 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to The increasing adoption of cell and gene therapies, The increasing focus on mRNA therapies, rising demand for cutting-edge treatments, improved efficiency and cost-effective solutions provided by outsourcing partners, and collaborative innovation. Major trends in the forecast period include technological advancement, rising expertise in advanced therapeutics, escalating pipeline of innovative therapies, the integration of cutting-edge technology, rapid advancements in gene therapy, cell therapy, and mRNA technologies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report
Scope Of Advanced Therapeutics Pharmaceutical Outsourcing Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Market Drivers –
The increasing adoption of cell and gene therapies is expected to propel the growth of the advanced therapeutics pharmaceutical outsourcing market going forward. Cell and gene therapies are innovative treatments that use living cells or genetic material to treat or cure diseases. Advanced therapeutics pharmaceutical outsourcing is used in cell and gene therapies to offer access to providers with proven track records and experienced personnel, saving companies time and resources in building their teams. For instance, in November 2023, according to a report by Nature, a UK-based scientific journal, the number of new patients treated with gene therapies is expected to increase from 16,244 in 2020 to 94,696 in 2025. Therefore, the increasing adoption of cell and gene therapies is driving the growth of the advanced therapeutics pharmaceutical outsourcing market.
Market Trends –
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market are focusing on strategic partnerships to provide reliable services to customers. A strategic partnership is a collaborative arrangement between two or more entities (typically businesses) formed to achieve mutually beneficial goals that each partner could not achieve independently. For instance, in January 2023, Lonza, a Switzerland-based manufacturing company for the pharmaceutical, biotechnology, and nutrition sectors, partnered with Context Therapeutics Inc., a US-based biopharmaceutical company advancing medicines for solid tumors. The partnership involves Lonza providing manufacturability assessment, gene, and cell line construction, and process development for the drug substance and drug product.
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Get an inside scoop of the advanced therapeutics pharmaceutical outsourcing market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
Regional Insights –
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2023. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Croda International Plc, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, Marken, AGC Biologics, Evotec SE, ProPharma Group, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cryoport Systems Inc., Cytovance Biologics
Table of Contents
1. Executive Summary
2. Advanced Therapeutics Pharmaceutical Outsourcing Market Report Structure
3. Advanced Therapeutics Pharmaceutical Outsourcing Market Trends And Strategies
4. Advanced Therapeutics Pharmaceutical Outsourcing Market – Macro Economic Scenario
5. Advanced Therapeutics Pharmaceutical Outsourcing Market Size And Growth
…..
27. Advanced Therapeutics Pharmaceutical Outsourcing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
